University of Toronto and Toronto Western Hospital, Mc13-310, 399 Bathurst Street, Toronto M5T 2S8.
Arthritis Res Ther. 2011;13(6):R215. doi: 10.1186/ar3548. Epub 2011 Dec 29.
The relative resistance of non-chondrodystrophic (NCD) canines to degenerative disc disease (DDD) may be due to a combination of anabolic and anti-catabolic factors secreted by notochordal cells within the intervertebral disc (IVD) nucleus pulposus (NP). Factors known to induce DDD include interleukin-1 beta (IL-1ß) and/or Fas-Ligand (Fas-L). Therefore we evaluated the ability of notochordal cell conditioned medium (NCCM) to protect NP cells from IL-1ß and IL-1ß +FasL-mediated cell death and degeneration.
We cultured bovine NP cells with IL-1ß or IL-1ß+FasL under hypoxic serum-free conditions (3.5% O2) and treated the cells with either serum-free NCCM or basal medium (Advanced DMEM/F-12). We used flow cytometry to evaluate cell death and real-time (RT-)PCR to determine the gene expression of aggrecan, collagen 2, and link protein, mediators of matrix degradation ADAMTS-4 and MMP3, the matrix protection molecule TIMP1, the cluster of differentiation (CD)44 receptor, the inflammatory cytokine IL-6 and Ank. We then determined the expression of specific apoptotic pathways in bovine NP cells by characterizing the expression of activated caspases-3, -8 and -9 in the presence of IL-1ß+FasL when cultured with NCCM, conditioned medium obtained using bovine NP cells (BCCM), and basal medium all supplemented with 2% FBS.
NCCM inhibits bovine NP cell death and apoptosis via suppression of activated caspase-9 and caspase-3/7. Furthermore, NCCM protects NP cells from the degradative effects of IL-1ß and IL-1ß+Fas-L by up-regulating the expression of anabolic/matrix protective genes (aggrecan, collagen type 2, CD44, link protein and TIMP-1) and down-regulating matrix degrading genes such as MMP-3. Expression of ADAMTS-4, which encodes a protein for aggrecan remodeling, is increased. NCCM also protects against IL-1+FasL-mediated down-regulation of Ank expression. Furthermore, NP cells treated with NCCM in the presence of IL-1ß+Fas-L down-regulate the expression of IL-6 by almost 50%. BCCM does not mediate cell death/apoptosis in target bovine NP cells.
Notochordal cell-secreted factors suppress NP cell death by inhibition of activated caspase-9 and -3/7 activity and by up-regulating genes contributing anabolic activity and matrix protection of the IVD NP. Harnessing the restorative powers of the notochordal cell could lead to novel cellular and molecular strategies in the treatment of DDD.
非软骨发育不良(NCD)犬种对退行性椎间盘疾病(DDD)的相对抗性可能是由于椎间盘(IVD)核髓核内脊索细胞分泌的合成代谢和抗分解代谢因子的组合。已知诱导 DDD 的因素包括白细胞介素-1β(IL-1β)和/或 Fas 配体(Fas-L)。因此,我们评估了脊索细胞条件培养基(NCCM)保护 NP 细胞免受 IL-1β和 IL-1β+FasL 介导的细胞死亡和变性的能力。
我们在低氧无血清条件(3.5%O2)下用 IL-1β或 IL-1β+FasL 培养牛 NP 细胞,并使用无血清 NCCM 或基础培养基(高级 DMEM/F-12)处理细胞。我们使用流式细胞术评估细胞死亡,实时(RT-)PCR 确定聚集蛋白聚糖、胶原 2 和连接蛋白、基质降解介体 ADAMTS-4 和 MMP3、基质保护分子 TIMP1、分化(CD)44 受体、炎症细胞因子 IL-6 和 Ank 的基因表达。然后,我们通过在存在 IL-1β+FasL 时使用 NCCM、使用牛 NP 细胞获得的条件培养基(BCCM)和补充有 2%FBS 的基础培养基培养牛 NP 细胞,来确定牛 NP 细胞中特定凋亡途径的表达,然后确定特定凋亡途径的表达。
NCCM 通过抑制活化的 caspase-9 和 caspase-3/7 抑制牛 NP 细胞死亡和凋亡。此外,NCCM 通过上调合成代谢/基质保护基因(聚集蛋白聚糖、胶原 2、CD44、连接蛋白和 TIMP-1)和下调基质降解基因(如 MMP-3)来保护 NP 细胞免受 IL-1β 和 IL-1β+Fas-L 的降解作用。编码聚集蛋白聚糖重塑的蛋白的 ADAMTS-4 表达增加。NCCM 还可防止 IL-1+FasL 介导的 Ank 表达下调。此外,在存在 IL-1β+Fas-L 的情况下用 NCCM 处理的 NP 细胞通过下调 IL-6 的表达将近 50%。BCCM 不会介导靶牛 NP 细胞的细胞死亡/凋亡。
脊索细胞分泌的因子通过抑制活化的 caspase-9 和 caspase-3/7 的活性并上调参与 IVD NP 合成代谢活性和基质保护的基因来抑制 NP 细胞死亡。利用脊索细胞的修复能力可能会导致退行性椎间盘疾病治疗的新的细胞和分子策略。